39 Publications (Page 1 of 2)
2020
Hemostatic efficacy of an advanced bipolar sealer in open gynecologic, thoracic, and colectomy procedures: A prospective cohort study
Schilder, JeanneSchilder, JeanneSchilder, JeanneAnderson, DavidAnderson, DavidAnderson, DavidShah, FatimaShah, FatimaShah, FatimaHolcomb, BryanHolcomb, BryanHolcomb, BryanShah, AhmarShah, AhmarShah, AhmarFullarton, GrantFullarton, GrantFullarton, GrantAshraf, ShazadAshraf, ShazadAshraf, ShazadFegan, ScottFegan, ScottFegan, ScottPaterson, HughPaterson, HughPaterson, HughSchwiers, Michael LSchwiers, Michael LSchwiers, Michael LSingleton, David WSingleton, David WSingleton, David WWaggoner, Jason RWaggoner, Jason RWaggoner, Jason RFryrear, RaymondFryrear, RaymondFryrear, RaymondRobb, Bruce WRobb, Bruce W and Robb, Bruce W
International Journal of Surgery Open, vol. 24, pp. 63, 2020. | Journal Article
2018
Cell Origins of High-Grade Serous Ovarian Cancer
Kim, JaeyeonKim, JaeyeonKim, JaeyeonPark, Eun YoungPark, Eun YoungPark, Eun YoungKim, OlgaKim, OlgaKim, OlgaSchilder, Jeanne MSchilder, Jeanne MSchilder, Jeanne MCoffey, Donna MCoffey, Donna MCoffey, Donna MCho, Chi-HeumCho, Chi-HeumCho, Chi-HeumBast, Robert CBast, Jr, Robert C and Bast, Jr, Robert C
Cancers, vol. 10, (no. 11), pp. 433, 2018-Nov-12. | Journal Article
 
High-Dose-Rate Brachytherapy (hdr-bt) Following Concurrent Chemoradiotherapy (crt) for Locally Advanced Cervical Cancer: Early Outcomes after Adoption of Mri-Guided Adaptive Volumetric Planning
Hinton, Jason DHinton, Jason DSchilder, JeanneSchilder, JeanneGuo, Gordon and Guo, Gordon
Brachytherapy, vol. 17, (no. 4), pp. S126, July-August 2018. | Journal Article
 
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study
Tew, William PTew, William PSill, Michael WSill, Michael WWalker, Joan LWalker, Joan LSecord, Angeles AlvarezSecord, Angeles AlvarezBonebrake, Albert JBonebrake, Albert JSchilder, Jeanne MSchilder, Jeanne MStuckey, AshleyStuckey, AshleyRice, LaurelRice, LaurelTewari, Krishnansu STewari, Krishnansu SAghajanian, Carol A and Aghajanian, Carol A
Gynecologic Oncology, vol. 151, (no. 2), pp. 263, November 2018. | Journal Article
2016
Abstract CT092: A phase II study of neoadjuvant abemaciclib (LY2835219) in postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer (neoMONARCH)
Hurvitz, Sara ASchilder, Jeanne MarieFrenzel, Martin and Martín, Miguel
Cancer Research, vol. 76, (no. 14 Supplement), pp. CT092, 2016-07-15. | Journal Article
 
Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Monk, Bradley JMonk, Bradley JSill, Michael WSill, Michael WWalker, Joan LWalker, Joan LDarus, Christopher JDarus, Christopher JSutton, GregorySutton, GregoryTewari, Krishnansu STewari, Krishnansu SMartin, Lainie PMartin, Lainie PSchilder, Jeanne MSchilder, Jeanne MColeman, Robert LColeman, Robert LBalkissoon, JaiBalkissoon, JaiAghajanian, Carol and Aghajanian, Carol
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 34, (no. 19), pp. 2286, 2016-07-01. | Journal Article
2015
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Bender, DavidBender, DavidBender, D.Bender, DavidSill, MichaelSill, M.W.Sill, MichaelSill, Michael WLankes, Heather ALankes, H.A.Lankes, HeatherLankes, HeatherReyes, H.D.Reyes, Henry DReyes, HenryReyes, HenryDarus, Christopher JDarus, ChristopherDarus, C.J.Darus, ChristopherDelmore, JamesDelmore, J.E.Delmore, James EDelmore, JamesRotmensch, J.Rotmensch, JacobRotmensch, JacobRotmensch, JacobGray, HeidiGray, H.J.Gray, HeidiGray, Heidi JMannel, R.S.Mannel, RobertMannel, Robert SMannel, RobertSchilder, JeanneSchilder, Jeanne MSchilder, JeanneSchilder, J.M.Hunter, M.I.Hunter, MarkHunter, MarkHunter, Mark IMcCourt, CarolynMcCourt, C.K.McCourt, CarolynMcCourt, Carolyn KSamuelson, MeganSamuelson, MeganSamuelson, M.I.Samuelson, Megan ILeslie, KimberlyLeslie, Kimberly KLeslie, Kimberly and Leslie, K.K.
Gynecologic Oncology, vol. 138, (no. 3), pp. 512, 2015. | Journal Article
2014
A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
Dizon, Don SDizon, DonSill, MichaelSill, Michael WSchilder, Jeanne MSchilder, JeanneMcGonigle, KathrynMcGonigle, Kathryn FRahman, ZiaRahman, ZiaMiller, David SMiller, DavidMutch, DavidMutch, David GLeslie, Kimberly K and Leslie, Kimberly
Gynecologic Oncology, vol. 135, (no. 3), pp. 445, 2014. | Journal Article
 
A randomized phase II trial of bevacizumab (BV) plus oral everolimus (EV) versus bevacizumab alone for recurrent or persistent epithelial ovarian (EOC), fallopian tube (FTC), or primary peritoneal cancer (PPC)
Tew, William PSill, MichaelMcMeekin, D. ScottSecord, Angeles AlvarezBonebrake, Albert JSchilder, JeanneStuckey, AshleyRice, LaurelTewari, Krishnansu Sujata and Aghajanian, Carol
Journal of Clinical Oncology, vol. 32, (no. 15_suppl), pp. 5546, 2014-05-20. | Journal Article
2012
Abstract 4275: PLA2activities in human epithelial ovarian cancer ascites
Xu, YanCai, QingchunZhao, ZhenwenAntalis, Caryl JYan, LiboHamed, Ali HStehman, Frederick BSchilder, Jeanne M and Priore, Giuseppe Del
Cancer Research, vol. 72, (no. 8 Supplement), pp. 4275, 2012-04-15. | Journal Article
 
Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer
Cai, QingchunZhao, ZhenwenAntalis, CarylYan, LiboDel Priore, GiuseppeHamed, Ali HassanStehman, Frederick BSchilder, Jeanne M and Xu, Yan
The FASEB Journal, vol. 26, (no. 8), pp. 3320, August 2012. | Journal Article
 
Epigenetic Resensitization to Platinum in Ovarian Cancer
Matei, Daniela EMatei, DanielaFang, FangFang, FangShen, ChangyuShen, ChangyuSchilder, Jeanne MSchilder, JeanneArnold, AleshaArnold, AleshaZeng, YanZeng, YanBerry, William ABerry, William AHuang, TimHuang, Tim HNephew, Kenneth P and Nephew, Ken
Cancer research, vol. 72, (no. 9), pp. 2205, 2012-May-01. | Journal Article
 
Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancer
Hess, LisaHess, LisaStehman, FrederickStehman, Frederick BMethod, Michael WMethod, MichaelWeathers, TessWeathers, TessGupta, ParidhaGupta, ParidhaSchilder, Jeanne and Schilder, Jeanne M
Gynecologic Oncology, vol. 127, (no. 3), pp. 568, 2012. | Journal Article
 
Patient Recall of Health Care Events and Time to Diagnose a Suspected Ovarian Cancer
Hess, LisaHess, LisaMethod, MichaelMethod, MichaelStehman, FrederickStehman, FrederickWeathers, TessWeathers, TessGupta, ParidhaGupta, ParidhaSchilder, Jeanne and Schilder, Jeanne
Clinical Ovarian and Other Gynecologic Cancer, vol. 5, (no. 1), pp. 23, 2012. | Journal Article
 
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study
Alvarez, Edwin AAlvarez, EdwinBrady, WilliamBrady, WilliamWalker, JoanWalker, Joan LRotmensch, JacobRotmensch, JacobZhou, Xun CZhou, XunKendrick, JamesKendrick, James EYamada, S.Yamada, S DSchilder, JeanneSchilder, Jeanne MCohn, DavidCohn, David EHarrison, Charles RHarrison, CharlesMoore, Kathleen NMoore, KathleenAghajanian, Carol and Aghajanian, Carol
Gynecologic Oncology, vol. 129, (no. 1), pp. 27, 2012. | Journal Article
 
Symptoms of Pelvic Floor Disorders and Quality of Life Measures in Postoperative Patients With Endometrial Cancer
Nosti, PatrickMcDermott, ColleenSchilder, JeanneStehman, Frederick and Woodman, Patrick
Clinical Ovarian and Other Gynecologic Cancer, vol. 5, (no. 1), pp. 30, 2012. | Journal Article
 
The Morphology Index: Predictive value of malignancy among clinicians at various levels of training
Barnsfather, KrisFitzpatrick, C.Wilson, JillLinn, CadyBrizendine, Edward and Schilder, Jeanne
Gynecologic Oncology, vol. 127, (no. 1), pp. 97, 2012. | Journal Article
2010
A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancer
Fang, FangFang, FangBalch, CurtisBalch, CurtSchilder, JeanneSchilder, Jeanne MBreen, TimothyBreen, TimothyZhang, ShuZhang, ShuShen, ChangyuShen, ChangyuLi, LangLi, LangKulesavage, CarolKulesavage, CarolSnyder, Anthony JSnyder, Anthony JNephew, Kenneth PNephew, KenMatei, Daniela E and Matei, Daniela E
Cancer, vol. 116, (no. 17), pp. 4053, 1 September 2010. | Journal Article
 
Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group
Kunos, Charles AKunos, CharlesSill, Michael WSill, MichaelBuekers, Thomas EBuekers, ThomasWalker, Joan LWalker, JoanSchilder, Jeanne MSchilder, JeanneYamada, S.Yamada, S DWaggoner, StevenWaggoner, Steven EMohiuddin, MohammedMohiuddin, MohammedFracasso, Paula M and Fracasso, Paula
Gynecologic Oncology, vol. 120, (no. 2), pp. 228, 2010. | Journal Article
2009
Activity of 2 methoxyestradiol (Panzem® NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial
Matei, DanielaMatei, Daniela ESchilder, JeanneSchilder, JeanneSutton, GregorySutton, GregoryPerkins, SusanPerkins, SusanBreen, TimBreen, TimQuon, CheckQuon, CheckSidor, Carolyn and Sidor, Carolyn
Gynecologic Oncology, vol. 115, (no. 1), pp. 96, 2009. | Journal Article
 
A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study
Fiorica, JamesFiorica, James VBlessing, JohnBlessing, John APuneky, Louis VPuneky, LouisAlverez Secord, AngelesSecord, AngelesHoffman, James SHoffman, JamesYamada, S.Yamada, S DBuekers, Thomas EBuekers, ThomasBell, JeffreyBell, JeffreySchilder, Jeanne and Schilder, Jeanne M
Gynecologic Oncology, vol. 115, (no. 2), pp. 289, 2009. | Journal Article
 
Indiana University Experience in the Management of Vaginal Cancer
Sinha, BedatriStehman, FredrickSchilder, JeanneClark, Lori and Cardenes, Higinia
International Journal of Gynecologic Cancer, vol. 19, (no. 4), pp. 693, 20090400. | Journal Article
 
Representations of Vaginal Symptoms in Cervical Cancer Survivors
Tornatta, Jennifer MTornatta, JenniferCarpenter, JanetCarpenter, Janet SSchilder, JeanneSchilder, JeanneCardenes, Higinia R and Cardenes, Higinia
Cancer Nursing, vol. 32, (no. 5), pp. 384, 2009-September/October. | Journal Article
2008
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, ShuZhang, ShuBalch, CurtBalch, CurtisChan, MichaelChan, Michael WLai, Hung-ChengLai, Hung-ChengMatei, Daniela EMatei, DanielaSchilder, JeanneSchilder, Jeanne MYan, PearllyYan, Pearlly SHuang, Tim HHuang, TimNephew, Kenneth and Nephew, Ken
Cancer Research, vol. 68, (no. 11), pp. 4320, 20080601. | Journal Article
 
Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial
Matei, DanielaMatei, DanielaMatei, Daniela EEmerson, Robert EEmerson, Robert EEmerson, Robert ESchilder, JeanneSchilder, JeanneSchilder, JeanneMenning, NancyMenning, NancyMenning, NancyBaldridge, Lee AnnBaldridge, Lee ABaldridge, Lee AnnJohnson, Cynthia SJohnson, Cynthia SJohnson, Cynthia SBreen, TimBreen, TimBreen, TimMcClean, JohnMcClean, JohnMcClean, JohnStephens, DoyleStephens, DoyleStephens, DoyleWhalen, CharlesWhalen, CharlesWhalen, CharlesSutton, GregorySutton, Gregory and Sutton, Gregory
Cancer, vol. 113, (no. 4), pp. 732, 2008-Aug-15. | Journal Article